Your shopping cart is currently empty

α4β1antagonist-1 (Compound 4) is a highly selective α4β1 integrin antagonist with an IC50 of 15 nM. It inhibits integrin-mediated cell adhesion and the activation of the ERK1/2 signaling pathway. α4β1antagonist-1 also exhibits partial agonist activity on αMβ2 integrin with an EC50 of 23 nM. This compound shows potential for research in chronic inflammatory diseases such as rheumatoid arthritis and multiple sclerosis, as well as in cancer.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | α4β1antagonist-1 (Compound 4) is a highly selective α4β1 integrin antagonist with an IC50 of 15 nM. It inhibits integrin-mediated cell adhesion and the activation of the ERK1/2 signaling pathway. α4β1antagonist-1 also exhibits partial agonist activity on αMβ2 integrin with an EC50 of 23 nM. This compound shows potential for research in chronic inflammatory diseases such as rheumatoid arthritis and multiple sclerosis, as well as in cancer. |
| Targets&IC50 | α4β1:15 nM |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.